BridgeMD
New treatment option for Complex Congenital Heart Disease
Official title Support for the Management of Parental Stress in Surgical Resuscitation of Congenital Heart Diseases
ClinicalTrials.gov ID: NCT06884046
What this study is testing
- What it's testing
- Half of children with congenital heart disease develop specific neurodevelopmental disorders. Neurodevelopmental disorders are the leading cause of morbidity in these children.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 to 28
You may be able to join if
- Parents whose fetus has congenital heart disease diagnosed in antenatal, which will be operated in the neonatal period (between 0 and 28 days of...
- Parents followed in the congenital heart disease sector of the University Hospital of Bordeaux as soon as the diagnosis is announced in antenatal.
- Free, informed and signed written consent of the couple or single mother in a single parent setting or by a third person (in case of physical...
- Person affiliated or beneficiary of a social security scheme (excluding AME).
- Parents with parental authority.
You likely can't join if
- Parents who do not understand or read French and cannot be accompanied by a third party for translation.
- Parents with major psychiatric disorders.
- Parents deprived of liberty due to ongoing legal proceedings.
- Parents under guardianship or curatorship or unable to personally express consent.
The study team makes the final eligibility decision.
Where it's taking place
- Pessac, France, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0 days to 28 days. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pessac, France, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.